Results 81 to 90 of about 73,644 (221)

Uncommon presentation of autoimmune limbic encephalitis: a case report

open access: yesNew Zealand Medical Student Journal
Autoimmune limbic encephalitis is an inflammatory condition of the brain that presents as an acute psychotic disorder. Investigations to confirm this diagnosis often have normal results, and so discriminating between a functional psychiatric presentation
Quintin Smith
doaj   +1 more source

Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis

open access: yesNeurology and Clinical Neuroscience, EarlyView.
ABSTRACT Background Autoimmune encephalitis therapy requires adjusting the regimen based on therapeutic response; however, clinical indicators of this response remain unknown. Aim To determine the predictive capability of cerebrospinal fluid (CSF), electroencephalography (EEG), and brain magnetic resonance imaging (MRI) in identifying responders to ...
Yuta Madokoro   +8 more
wiley   +1 more source

Clinical features of limbic encephalitis with LGI1 antibody

open access: yes, 2017
Meiling Wang,1,2,* Xiaoyu Cao,2,* Qingxin Liu,2 Wenbin Ma,1,2 Xiaoqian Guo,1,3 Xuewu Liu1 1Department of Neurology, Qilu Hospital of Shandong University, Jinan, 2Department of Neurology, Binzhou Medical University Hospital, Binzhou, 3Department of ...
Liu QX   +5 more
core  

Spontaneous remission without progression to limbic encephalitis in a patient with LGi1 seropositive faciobrachial dystonic seizure [PDF]

open access: yes, 2016
Faciobrachial dystonic seizures are pathognomonic of leucine-rich glioma inactivated-1 (LGi1) antibody, non-paraneoplastic limbic encephalitis. Faciobrachial dystonic seizures usually precede limbic encephalitis by about a month.
Tan, C.T.   +4 more
core   +2 more sources

Improving enteral nutrition in patients requiring neurological intensive care unit care: A retrospective study on a novel bedside nasointestinal tube placement technique

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background This study aimed to develop and assess a bedside nasojejunal tube placement technique designed for resource‐limited settings to address the specific challenges of enteral nutrition (EN) delivery in neurocritical care patients, particularly those at high risk of reflux and aspiration. The technique sought to overcome the drawbacks of
Niuchenglin   +5 more
wiley   +1 more source

Autoimmune encephalitis in a woman with lung adenocarcinoma undergoing treatment with an immune checkpoint inhibitor (Pembrolizumab). What was the trigger: The neoplasm or the treatment?

open access: yesCurrent Problems in Cancer: Case Reports
Autoimmune encephalitis is a condition where patients typically present with short-term memory deficits, psychiatric symptoms, and seizures, all with rapid progression.
Esteban Solís Viveros   +6 more
doaj   +1 more source

Improvement of Paraneoplastic Limbic Encephalitis after Systemic Treatment with Rituximab in a Patient with B-Cell Chronic Lymphocytic Leukemia

open access: yesCase Reports in Hematology, 2013
Limbic encephalitis is an inflammatory disease of the central nervous system characterized by diverse neurologic symptoms including mnestic disturbances, hallucinations, and seizures as well as behavioral symptoms like depression, personality changes ...
Hendrik Nogai   +3 more
doaj   +1 more source

A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody

open access: yesAnnals of Indian Academy of Neurology, 2016
Antibodies to GAD-65 have been implicated in the pathogenesis of type 1 diabetes , limbic encephalitis and Stiff person syndrome, however these diseases rarely occur concurrently.
Chandra Mohan Sharma   +4 more
doaj   +1 more source

Effectiveness and safety of efgartigimod in patients with anti‐NMDAR or anti‐LGI1 encephalitis and its 18F‐DPA714 PET imaging evaluation: A multicenter, single‐arm, prospective, observational real‐world study

open access: yesNeuroprotection, EarlyView.
Abstract Background Efgartigimod disrupts the recycling of pathogenic IgG autoantibodies and may represent a candidate therapy for autoimmune encephalitis. This real‐world study evaluated the clinical efficacy, safety, and impact of efgartigimod on brain inflammation.
Huanyu Meng   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy